[HTML][HTML] Mitochondrial channels: ion fluxes and more

I Szabo, M Zoratti - Physiological reviews, 2014 - journals.physiology.org
The field of mitochondrial ion channels has recently seen substantial progress, including the
molecular identification of some of the channels. An integrative approach using genetics …

[HTML][HTML] Ion channels in the regulation of apoptosis

A Kondratskyi, K Kondratska, R Skryma… - … et Biophysica Acta (BBA …, 2015 - Elsevier
Apoptosis, a type of genetically controlled cell death, is a fundamental cellular mechanism
utilized by multicellular organisms for disposal of cells that are no longer needed or …

Voltage-gated potassium channel Kv1. 3 as a target in therapy of cancer

A Teisseyre, A Palko-Labuz, K Sroda-Pomianek… - Frontiers in …, 2019 - frontiersin.org
Voltage-gated potassium channel Kv1. 3 is an integral membrane protein, which is
selectively permeable for potassium ions and is activated upon a change of membrane …

[HTML][HTML] Targeting mitochondrial ion channels for cancer therapy

I Szabo, M Zoratti, L Biasutto - Redox Biology, 2021 - Elsevier
Pharmacological targeting of mitochondrial ion channels is emerging as a promising
approach to eliminate cancer cells; as most of these channels are differentially expressed …

Strategies for the improvement of metal-based chemotherapeutic treatments

D Cirri, F Bartoli, A Pratesi, E Baglini, E Barresi… - Biomedicines, 2021 - mdpi.com
This article provides an overview of the various research approaches we have explored in
recent years to improve metal-based agents for cancer or infection treatments. Although …

[HTML][HTML] Pharmacological targeting of ion channels for cancer therapy: in vivo evidences

L Leanza, A Manago, M Zoratti, E Gulbins… - Biochimica et Biophysica …, 2016 - Elsevier
Since the discovery of the participation of various ion channels in the regulation of cell
proliferation and programmed cell death two decades ago, the field exploring ion channel …

[HTML][HTML] Clofazimine: A journey of a drug

J Xu, A Koval, VL Katanaev - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Among different strategies to develop novel therapies, drug repositioning (aka repurposing)
aims at identifying new uses of an already approved or investigational drug. This approach …

The voltage-gated potassium channel Kv1. 3 is a promising multitherapeutic target against human pathologies

M Perez-Verdaguer, J Capera… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: The voltage-dependent potassium channel Kv1. 3 is mainly present in the
nervous and immune systems. In leukocytes, Kv1. 3 fine-tunes the activation and …

Ion channels: New actors playing in chemotherapeutic resistance

P Kischel, A Girault, L Rodat-Despoix, M Chamlali… - Cancers, 2019 - mdpi.com
In the battle against cancer cells, therapeutic modalities are drastically limited by intrinsic or
acquired drug resistance. Resistance to therapy is not only common, but expected: if …

The combined activation of KCa3. 1 and inhibition of Kv11. 1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells

S Pillozzi, M D'Amico, G Bartoli, L Gasparoli… - British journal of …, 2018 - nature.com
Background: Platinum-based drugs such as Cisplatin are commonly employed for cancer
treatment. Despite an initial therapeutic response, Cisplatin treatment often results in the …